Research and analysis at the cutting edge of medicine.
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 82 | Founded | a year ago | Last Issue | 2 days ago |
| Active | |||||
Read this Newsletter
breakingground.substack.comLatest Issues
Every breakthrough in medicine in 2026... so far
In cancer, cardiovascular, autoimmunity, neurology, and metabolic medicine.
Three-quarters through the year, it’s time to look at what’s been achieved so far.
Every first-in-class drug entering human trials in China this year
All 160 novel programs
I recently went to China for its biggest cancer conference (CSCO) and it’s clear there is a lot of novel science happening. The frontier of science is the first-in-human clinical trial — where a new drug is tested in...
Do smaller biotechs generate better returns?
Yes they do (but only if backed by specialist investors).
Research from the quantitative hedge fund, Verdad, found that the segment of the biotech universe with the strongest returns is the smallest companies with the most specialist owner...
Can we predict the results of clinical trials?
Dr. Thore Buergel is CEO at Pheiron, a company dedicated to predicting clinical trials using AI and big data.
We spoke about the data needed to do this, who the customer is, and about this year’s big trials (Novo Nordisk’s ZEUS trial, Nova...
A ranking of every biotech company
All 589 companies ranked, using Verdad’s quantitative investment model
The hedge fund, Verdad Capital, just published their quantitative model for biotech investing. They showed that companies with the highest scores have the best returns,...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Breakthrough.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
SEO Reach
Where Breakthrough ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 52 | Monthly Search Traffic | Top Keywords |
|---|
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #108 |
Authors
The writers behind this newsletter.
Doctor, scientist | Trying to speed up science and solve disease
PhD student investigating head and neck cancer immunology, MD, Science communicator
Frequently Asked Questions
How can I access the email archive for Breakthrough?
You can find recent issues that have been published by Breakthrough on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Breakthrough have?
To see how many people subscribe to Breakthrough, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Breakthrough?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Breakthrough as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Breakthrough?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Breakthrough using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Breakthrough?
Scroll up to where it says Related Newsletters to see other publications like Breakthrough. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Breakthrough?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.